Affordable Access

[Human pharmacokinetics of AR-L 115 BS (author's transl)].

Authors
Type
Published Article
Journal
Arzneimittel-Forschung
Publication Date
Volume
31
Issue
1a
Pages
236–239
Identifiers
PMID: 7195229
Source
Medline

Abstract

Following i.v. administration of 0.7 mg of 2-[(2-methoxy-4-methylsulfinyl)phenyl]-1H-imidazo[4,5-b]pyridine (AR-L 115 BS)/kg (bolus) the terminal plasma elimination half-life (beta-phase) was in the range of 50 min. A fast absorption of the patent compound could be observed after oral administration of 50, 75, 10 and 150 mg AR-L 115 BS (solution). The AR-L 115 BS plasma level behaviour was characterised by a fast elimination of the parent compound.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments
F